<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03823859</url>
  </required_header>
  <id_info>
    <org_study_id>EKNZ 2018-01961</org_study_id>
    <nct_id>NCT03823859</nct_id>
  </id_info>
  <brief_title>Metabolomics of Thyroid Hormones</brief_title>
  <acronym>MATcH</acronym>
  <official_title>Metabolomics of Thyroid Hormones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ETH Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to develop a metabolome signature of thyroid hormone status. The&#xD;
      metabolome signature could be useful in diagnosis and treatment of thyroid dysfunction&#xD;
      diseases, especially in cases where TSH cannot be reliably used.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Hypothyroidism is a frequent endocrine disorder, where the thyroid gland does not&#xD;
      produce sufficient amounts of thyroid hormones. The substitution therapy is guided by&#xD;
      measurement of the pituitary gland hormone thyrotropin (TSH). Patients with central&#xD;
      hypothyroidism in whom pituitary insufficiency leads to hypothyroidism, TSH cannot be used to&#xD;
      guide therapy. So far there are no reliable methods for therapy control in patients with&#xD;
      central hypothyroidism.&#xD;
&#xD;
      The measurement of small endogenous metabolites might give investigators a metabolomics&#xD;
      profile. This could help to discriminate between euthyroid, hypothyroid and hyperthyroid&#xD;
      state and therefore could be used for diagnosis and therapy control of thyroid dysfunction&#xD;
      diseases.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 12, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">July 28, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Metabolome signature of thyroid Hormone Status (MSTH)</measure>
    <time_frame>baseline/single visit</time_frame>
    <description>The MSTH will be tested against the current standard of diagnosis which is serum TSH level by multiple linear regression.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting energy expenditure (REE)</measure>
    <time_frame>baseline/single visit</time_frame>
    <description>Comparison of REE of healthy volunteers and Patients with thyroid dysfunction, measured by indirect calorimetry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition concerning muscle mass</measure>
    <time_frame>baseline/single visit</time_frame>
    <description>Comparison of muscle mass of healthy volunteers and patients with thyroid dysfunction, measured by DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition concerning fat mass</measure>
    <time_frame>baseline/single visit</time_frame>
    <description>Comparison of fat mass of healthy volunteers and patients with thyroid dysfunction, measured by DXA</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">332</enrollment>
  <condition>Central Hypothyroidism</condition>
  <condition>Hypothyroidism</condition>
  <condition>Hyperthyroidism</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <description>Blood sampling (fT3, fT4, TSH, Lipids, Glucose, HbA1c)&#xD;
Indirect calorimetry&#xD;
Dual energy X-ray Absorptiometry (DXA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with thyroid dysfunction</arm_group_label>
    <description>Patients with Primary hypothyroidism newly diagnosed, Primary hypothyroidism substituted, hyperthyroidism, secondary hypothyroidism&#xD;
Blood sampling (fT3, fT4, TSH, Lipids, Glucose, HbA1c)&#xD;
Indirect calorimetry&#xD;
Dual energy X-ray Absorptiometry (DXA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Indirect calorimetry</intervention_name>
    <description>Resting energy expenditure</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with thyroid dysfunction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dual energy X-ray Absorptiometry (DXA)</intervention_name>
    <description>Body composition</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with thyroid dysfunction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>fT4, fT3, TSH, HDL, LDL, triglycerides, cholesterol, HbA1c, Glucose Thyroid panel</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with thyroid dysfunction</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers will be recruited by means of advertisements (online or in the&#xD;
        newspaper).&#xD;
&#xD;
        Patients will be recruited from the endocrinology outpatient clinics of the Department of&#xD;
        Endocrinology, Diabetes and Metabolism, University Hospital Basel and patients referred&#xD;
        from practicing endocrinologists.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All participants:&#xD;
&#xD;
          -  Age 18 to 80 years&#xD;
&#xD;
          -  BMI 19 to 35 kg/m2&#xD;
&#xD;
          -  Informed consent as documented by signature&#xD;
&#xD;
        A) Patients with primary hyperthyroidism TSH &lt; 0.2 mIU/l and free thyroxine (fT4) &gt; 25 pM&#xD;
        or fT3 &gt; 8 pM&#xD;
&#xD;
        B) Patients with primary hypothyroidism, currently not sufficiently substituted TSH &gt; 8&#xD;
        milli-International unit (mIU)/l or fT4 &lt; 10 pM&#xD;
&#xD;
        C) Patients with diagnosis of primary hypothyroidism, sufficiently substituted Documented&#xD;
        diagnosis of primary hypothyroidism Substitution with L-Thyroxin TSH in target range&#xD;
        between 0.5 and 2.5 mIU/l&#xD;
&#xD;
        D) Patients with secondary hypothyroidism Pituitary disease with documented secondary&#xD;
        hypothyroidism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes mellitus (HbA1c &gt;6.5%)&#xD;
&#xD;
          -  Severe concomitant diseases: chronic heart failure, liver cirrhosis, kidney failure,&#xD;
             active cancer&#xD;
&#xD;
          -  Abuse of alcohol or illicit drugs&#xD;
&#xD;
          -  Women who are pregnant or breast feeding&#xD;
&#xD;
          -  Inability to follow the procedures of the study, e.g. due to language problems,&#xD;
             psychological disorders, dementia, etc. of the participant&#xD;
&#xD;
          -  Previous enrolment into the current study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Betz, PD Dr. med.</last_name>
    <role>Study Director</role>
    <affiliation>Klinik Endokrinologie, Diabetes und Metabolismus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Basel, Department of Endocrinology</name>
      <address>
        <city>Basel</city>
        <state>BS</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 28, 2019</study_first_submitted>
  <study_first_submitted_qc>January 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2019</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypothyroidism</keyword>
  <keyword>Metabolomics</keyword>
  <keyword>Thyroid Hormones</keyword>
  <keyword>Hyperthyroidism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothyroidism</mesh_term>
    <mesh_term>Hyperthyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

